| __timestamp | Grifols, S.A. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 660772000 | 72471000 |
| Thursday, January 1, 2015 | 736435000 | 89204000 |
| Friday, January 1, 2016 | 775266000 | 106010000 |
| Sunday, January 1, 2017 | 860348000 | 137905000 |
| Monday, January 1, 2018 | 814775000 | 159888000 |
| Tuesday, January 1, 2019 | 942821000 | 158425000 |
| Wednesday, January 1, 2020 | 985616000 | 200677000 |
| Friday, January 1, 2021 | 1061508000 | 304759000 |
| Saturday, January 1, 2022 | 1190423000 | 377221000 |
| Sunday, January 1, 2023 | 1254234000 | 336361000 |
In pursuit of knowledge
In the competitive pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Grifols, S.A. and Supernus Pharmaceuticals, Inc. have taken different paths in this regard over the past decade. From 2014 to 2023, Grifols, S.A. consistently reported higher SG&A expenses, peaking at approximately 1.25 billion in 2023. In contrast, Supernus Pharmaceuticals, Inc. maintained a more conservative approach, with expenses reaching around 336 million in the same year.
Despite Grifols' higher absolute costs, their expenses grew by about 90% over the period, while Supernus saw a staggering 364% increase. This suggests that while Grifols operates on a larger scale, Supernus is rapidly expanding its operational footprint. Investors and analysts should consider these trends when evaluating the companies' financial health and strategic direction.
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Grifols, S.A.
Who Optimizes SG&A Costs Better? GSK plc or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bio-Techne Corporation vs Supernus Pharmaceuticals, Inc.
Comparing SG&A Expenses: Catalent, Inc. vs Supernus Pharmaceuticals, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Exelixis, Inc. and Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Grifols, S.A. vs Cytokinetics, Incorporated
Cost Insights: Breaking Down Grifols, S.A. and Supernus Pharmaceuticals, Inc.'s Expenses
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and Mesoblast Limited
Grifols, S.A. vs Xencor, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Supernus Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Merus N.V. and Supernus Pharmaceuticals, Inc.
HUTCHMED (China) Limited vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends